Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | G6PD | P11413 | 4/20 | 0.47 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
| ▸ | MMP12 | P39900 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13632489 | 1.00 | G6PD (0.47) | G6PDLGALS8GAACA1CA2 | |
| SCHEMBL25496859 | 0.83 | PRKD3 (0.45) | GAACA1CA2CA9 | |
| SCHEMBL21706809 | 0.83 | G6PD (0.44) | G6PDLGALS8CA1CA2CA9 | |
| SCHEMBL5679954 | 0.81 | G6PD (0.49) | G6PDLGALS8GAACA1CA2 | |
| SCHEMBL14257075 | 0.81 | G6PD (0.45) | G6PDGAACA1CA2CA9 | |
| SCHEMBL13955990 | 0.81 | G6PD (0.45) | G6PDGAACA1CA2CA9 | |
| SCHEMBL23788328 | 0.81 | G6PD (0.49) | G6PDLGALS8GAACA1CA2 | |
| SCHEMBL402992 | 0.81 | G6PD (0.45) | G6PDGAACA1CA2CA9 | |
| SCHEMBL17191619 | 0.81 | G6PD (0.45) | G6PDGAACA1CA2CA9 | |
| SCHEMBL25525890 | 0.79 | IGF2R (0.40) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110112044-A1 | NOVEL USES OF D-MANNOPYRANOSE DERIVATIVES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110112044-A1 | NOVEL USES OF D-MANNOPYRANOSE DERIVATIVES | M6PR, BMP6, DCPS | G6PD 206/4885LGALS8 49/4885GAA 3551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.